Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06353776
Status:
COMPLETED
Last Update Posted:
2024-04-09
First Post:
2024-03-25
Brief Title:
MicroPulse Transscleral Laser Therapy and Its Short-term Impact on Ocular Surface
Sponsor:
University Tunis El Manar
Organization:
University Tunis El Manar
Study Overview
Official Title:
MicroPulse Transscleral Laser Therapy and Its Short-term Impact on Ocular Surface
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
MicroPulse transscleral laser therapy TLT is proven to be effective in reducing intraocular pressure with minimal complications in either primary or secondary glaucoma However its impact on the human ocular surface remains unexplored This study aims to bridge this gap by examining the clinical and histopathological effects of MicroPulse TLT on the ocular surface
Detailed Description:
This prospective study conducted at Mohamed Taher Maamouri University Hospital in Nabeul Tunisia investigates the clinical and histopathological short-term effects of MicroPulse transscleral laser therapy TLT on the ocular surface The study involves 16 eyes from 15 adult patients Participants underwent MicroPulse TLT followed by conjunctival biopsies for the analysis of inflammation and fibrosis Participants also benefited from ophthalmological examination and responded to the Ocular Surface Disease Index OSDI questionnaire before and after MicroPulse TLT
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None